ARTICLE | Tools & Techniques
Network revival
e-Therapeutics refocusing systems biology from repurposing to drug discovery
July 30, 2012 7:00 AM UTC
With its first two repurposed products now in the clinic, e-Therapeutics plc is branching out into drug discovery using the same systems biology platform that helped it identify its clinical-stage compounds.
The platform is built upon the theory of network pharmacology, which suggests compounds should be designed to affect multiple nodes in a network of targets that work together to drive a given cellular process...